Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

nitpicker

(7,153 posts)
3. Link to DW
Tue Aug 13, 2019, 02:07 AM
Aug 2019
https://www.dw.com/en/ebola-drugs-saving-lives-after-clinical-trials/a-49999347

(snip)
Which drugs were in the trial?
Regeneron's REGN-EB3
US National Institutes of Health's 'mAb114'
Mapp Biopharmaceutical's ZMapp
Gilead Sciences' Remdesivir
(snip)

In the study, fewer people died among those given the Regeneron drug or the NIH's — about 30% compared to half who received ZMapp. More striking, when patients sought care early — before too much virus was in their bloodstream - mortality was just 6% with the Regeneron drug and 11% with the NIH compound, compared to about 24% for ZMapp, Fauci said.
(snip)

Recommendations

0 members have recommended this reply (displayed in chronological order):

This is FANTASTIC news!!! AllyCat Aug 2019 #1
Well there's some good news! calimary Aug 2019 #2
Link to DW nitpicker Aug 2019 #3
However, BBC radio raised a point nitpicker Aug 2019 #4
Latest Discussions»Issue Forums»Health»Ebola now curable after t...»Reply #3